We have recently reported a new family of iminosugars in
which the endocyclic sp3 amine-type nitrogen atom has been
replaced by a neutral or very weakly basic pseudoamide-type
nitrogen (urea, thiourea, carbamate) with substantial sp2 char-
acter (“sp2-azasugars”).8 This subtle structural change substan-
tially modifies the reactivity and the stereoelectronic properties
at the pseudoanomeric region, with a dramatic increase in the
anomeric effect, which has been exploited in the design of
conformationally and configurationally stable reducing glyco-
mimetics in the indolizidine series (see structures 1 and 2 for
castanospermine and swainsonine analogues, respectively), some
of which behaved as highly selective and potent R-glucosidase
inhibitors.9
Synthesis and Biological Evaluation of
Guanidine-Type Iminosugars
Matilde Aguilar,† Paula D´ıaz-Pe´rez,†
M. Isabel Garc´ıa-Moreno,† Carmen Ortiz Mellet,*,† and
Jose´ M. Garc´ıa Ferna´ndez*,‡
Departamento de Qu´ımica Orga´nica, Facultad de Qu´ımica,
UniVersidad de SeVilla, Profesor Garc´ıa Gonza´lez 1, E-41012
SeVilla, Spain, and Instituto de InVestigaciones Qu´ımicas, CSIC
- UniVersidad de SeVilla, Ame´rico Vespucio 49, Isla de la
Cartuja, E-41092 SeVilla, Spain
mellet@us.es; jogarcia@iiq.csic.es
ReceiVed NoVember 7, 2007
Our general synthetic strategy to access sp2-azasugars is based
on the ability of the masked carbonyl group of an hexose
The preparation of carbohydrate mimics in which the
endocyclic oxygen has been replaced by a guanidine-type
nitrogen atom is reported. The synthetic strategy involves
the furanose f piperidine rearrangement of 5-deoxy-5-
guanidino-L-idose precursors. The reaction proceeds through
elimination of water to give 3-oxopiperidines, which were
isolated as the corresponding hydrates. Biological evaluation
of the new glycomimetics evidenced a strong influence of
the nature of the substituents at the nitrogen atoms on the
glycosidase inhibitory properties.
(3) (a) Sun, J.-Y.; Zhu, M.-Z.; Wang, S.-W.; Miao, S.; Xie, Y.-H.; Wang,
J.-B. Phytomedicine 2007, 14, 353. (b) Paulsen, H.; Brockhausen, I.
Glycoconjugate J. 2001, 18, 867. (c) Gross, P. E.; Baker, M. A.; Carver, J.
P.; Dennis, J. W. Clin. Cancer Res. 1995, 1, 935.
(4) (a) Anzeveno, P. B.; Creemer, L. J.; Daniel, J. K.; King, C.-H. R.;
Liu, P. S. J. Org. Chem. 1989, 54, 2539-2542. (b) Balfour, J. A.; McTavish,
D. Drugs 1993, 46, 1025.
(5) (a) Cren, S.; Gurcha, S. S.; Blake, A. J.; Besra, G. S.; Thomas, N. R.
Org. Biomol. Chem. 2004, 2, 2418. (b) Wrodnigg, T. M.; Sprenger, F. K.
Mini-ReV. Med. Chem. 2004, 4, 437.
(6) (a) Butters, T. D.; Dwek, R. A.; Platt, F. M. Chem. ReV. 2000, 100,
4683. (b) Cox, T. M.; Aerts, J. M. F. G.; Andria, G.; Beck, M.; Belmatoug,
N.; Bembi, B.; Chertkoff, R.; Vom Dahl, S.; Elstein, D.; Erickson, A.; Giralt,
M.; Heitner, R.; Hollak, C.; Hrebicek, M.; Lewis, S.; Mehta, A.; Pastores,
G. M.; Rolfs, A.; Miranda, M. C. S.; Zimran, A. J. Inherit. Metab. Dis.
2003, 26, 513. (c) Matsuda, J.; Suzuki, O.; Oshima, A.; Yamamoto, Y.;
Noguchi, A.; Takimoto, K.; Itoh, M.; Matsuzaki, Y.; Yasuda, Y.; Ogawa,
S.; Sakata, Y.; Nanba, E.; Higaki, K.; Ogawa, Y.; Tominaga, L.; Ohno, K.;
Iwasaki, H.; Watanabe, H.; Brady, R O.; Suzuki, Y. Proc. Nat. Acad. Sci.
U.S.A. 2003, 100, 15912.
(7) For reviews, see: (a) Broges de Melo, E.; da Silveira Gome, A.;
Carvalho, I. Tetrahedron 2006, 62, 10277. (b) Pearson, M. S. M.; Mathe´-
Allainmat, M.; Fargeas, V.; Lebreton, J. Eur. J. Org. Chem. 2005, 2159.
(c) Afarinkia, K.; Bahar, A. Tetrahedron: Asymmetry 2005, 16, 1239. (d)
Germain, D. P. Clin. Genet. 2004, 65, 77-86. (e) Cipolla, L.; La Ferla, B.;
Nicotra, F. Curr. Top. Med. Chem. 2003, 3, 1349. (f) Compain, P.; Martin,
O. R. Curr. Top. Med. Chem. 2003, 3, 541. (g) Asano, N. Curr. Top. Med.
Chem. 2003, 3, 471. (h) Lillelund, V. H.; Jensen, H. H.; Liang, X.; Bols,
M. Chem. ReV. 2002, 102, 515. (i) Asano, N.; Nash, R. J.; Molyneux, R.
J.; Fleet, G. W. J. Tetrahedron: Asymmetry 2000, 11, 1645. (j) Simmonds,
M. S. J.; Kite, G. C.; Porter, E. A. Taxonomic Distribution of Iminosugars
in Plants and Their Biological Activities. In Iminosugars as Glycosidase
Inhibitors; Stu¨tz, A., Ed.; Wiley-VCH: Weinheim, Germany 1999; p 8.
(8) (a) Garc´ıa-Moreno, M. I.; Ortiz Mellet, C.; Garc´ıa Ferna´ndez, J. M.
Tetrahedron 2007, 63, 7879. (b) Garc´ıa-Moreno, M. I.; D´ıaz-Pe´rez, P.; Ortiz
Mellet, C.; Garc´ıa Ferna´ndez, J. M. Eur. J. Org. Chem. 2005, 2903. (c)
Garc´ıa-Moreno, M. I.; Rodr´ıguez-Lucena, D.; Ortiz Mellet, C.; Garc´ıa
Ferna´ndez, J. M. J. Org. Chem. 2004, 69, 3578.
(9) (a) D´ıaz-Pe´rez, P.; Garc´ıa-Moreno, M. I.; Ortiz Mellet, C.; Garc´ıa
Ferna´ndez, J. M. J. Org. Chem. 2003, 68, 8890. (b) Garc´ıa-Moreno, M. I.;
D´ıaz-Pe´rez, P.; Ortiz Mellet, C.; Garc´ıa Ferna´ndez, J. M. Synlett 2003, 341.
(c) Garc´ıa-Moreno, M. I.; D´ıaz-Pe´rez, P.; Ortiz Mellet, C.; Garc´ıa Ferna´ndez,
J. M. Chem. Commun. 2002, 848. (d) D´ıaz Pe´rez, V. M.; Garc´ıa-Moreno,
M. I.; Ortiz Mellet, C.; Fuentes, J.; Garc´ıa Ferna´ndez, J. M.; D´ıaz Arribas,
J. C.; Can˜ada, F. J. J. Org. Chem. 2000, 65, 136. (e) Jime´nez Blanco, J. L.;
D´ıaz Pe´rez, V. M.; Ortiz Mellet, C.; Fuentes, J.; Garc´ıa Ferna´ndez, J. M.;
D´ıaz Arribas, J. C.; Can˜ada, F. J. Chem. Commun. 1997, 1969.
Polyhydroxylated alkaloids with iminosugar structure, usually
referred to as azasugars,1 display a broad range of interesting
biological activities potentially useful in the treatment of
ailments as varied as viral infections,2 including human immu-
nodeficiency virus (HIV),2a-e human hepatitis C (HCV),2f,g or
dengue virus,2i cancer,3 diabetes,4 tuberculosis,5 and lysosomal
storage diseases.6 The tremendous therapeutic potential of this
class of compounds has been ascribed to their ability to interact
with carbohydrate-processing enzymes, acting as competitive
inhibitors of glycosidases and/or glycosyltransferases, and has
strongly stimulated research in this area of glycobiology.7
† Universidad de Sevilla.
‡ Instituto de Investigaciones Qu´ımicas, CSIC - Universidad de Sevilla.
(1) Although the term “azasugar” is widely used in the literature to refer
to glycomimetics where the endocyclic oxygen atom has been replaced by
nitrogen, the term is not strictly correct according to the IUPAC-IUMB
nomenclature recommendations for carbohydrates, the accepted term being
“iminosugar”. See: McNaught, A. D. Pure Appl. Chem. 1996, 68, 1919.
(2) (a) Ratner, L.; Heyden, N. V.; Dedera, D. Virology 1991, 181, 180.
(b) Rudd, P. M.; Elliott, T.; Cresswell, P.; Wilson, I. A.; Dwek, R. A. Science
2001, 291, 2370. (c) Chery, F.; Cronin, L.; O’Brien, J. L.; Murphy, P. V.
Tetrahedron 2004, 60, 6597. (d) Lee, D.-S.; Jung, K.-E.; Yoon, C.-H.; Lim,
H.; Bae, Y.-S. Antimicrob. Agents Chemother. 2005, 49, 4110. (e) Greimel,
P.; Spreitz, J.; Stu¨tz, A. E.; Wrodnigg, T. M. Curr. Top. Med. Chem. 2003,
3, 513. (f) Alper, J. Science 2001, 291, 2338. (g) Pavlovic, D.; Neville, D.
C. A.; Argaud, O.; Blumberg, B.; Dwek, R. A.; Fischer, W. B.; Zitzmann,
N. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 6104. (h) Durantel, D.; Carrouee´-
Durantel, S.; Branza-Nichita, N.; Dwek, R. A.; Zitzmann, N. Antimicrob.
Agents Chemother. 2004, 48, 497. (i) Wu, S.-F.; Lee, C.-J.; Liao, C.-L.;
Dwek, R. A.; Zitzmann, N.; Lin, Y.-L. J. Virol. 2002, 76, 3596.
10.1021/jo702374f CCC: $40.75 © 2008 American Chemical Society
Published on Web 01/24/2008
J. Org. Chem. 2008, 73, 1995-1998
1995